Between Oct 1 , 2003 , and June 30 , 2011 , we enrolled eligible patients aged 1-24 years and initially categorised them into clinical standard-risk , intermediate-risk , and high-risk groups on the basis of a combination of National Cancer Institute criteria , cytogenetics , and early morphological response to induction therapy .